ADAPTIVE BIOTECHNOLOGIES

ADPTNASDAQ

🏆 #1383 by market capEarnings Nov 4US Equity

$24.97▼ $0.41 (−1.65%)

Live

1h—

24h▼ 1.6%

7d—

14d—

30d—

1y—

🏦Market Cap

$3.97B

Small Cap

📈Revenue Growth (YoY)

+50.1%

High Growth

📊Gross Margin

75.6%

High

💵FCF Margin

—

⚖️P/S Ratio

13.3x

Elevated

Otter Score

41

Weak

Earnings

Q3 · 2026Reported 2026-07-29

Earnings Per Share

Actual

-0.25

Expected

-0.13

miss

−87.10%

YoY −47.10%

Revenue

Actual

$71.55M

Expected

$65.44M

beat

+9.30%

YoY +21.50%

Consensus estimates

Recent quarters

Q3 2026

-0.25

miss

Q2 2026

-0.13

beat

Q1 2026

-0.09

beat

Q4 2025

0.06

beat